Alphagan p and Indapamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alphagan p (brimonidine tartrate) and Indapamide (indapamide). Common drug interactions include drug ineffective among females and altered state of consciousness among males.

The phase IV clinical study analyzes what interactions people have when they take Alphagan p and Indapamide. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Alphagan p?

Alphagan p has active ingredients of brimonidine tartrate. It is often used in glaucoma. eHealthMe is studying from 6,579 Alphagan p users. Check the latest studies of Alphagan p.

What is Indapamide?

Indapamide has active ingredients of indapamide. It is often used in high blood pressure. eHealthMe is studying from 22,152 Indapamide users. Check the latest studies of Indapamide.

On Jul, 29, 2026

11 people who take Alphagan p and Indapamide together, and have interactions are studied.

Alphagan p and Indapamide drug interactions.

What are the common drug interactions of Alphagan P and Indapamide, by gender? *:

female:

Drug ineffective
Eye swelling
Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
Hypopnoea (decrease in the breathing rate)
Intraocular pressure increased
Nasal dryness (dry nose)
Nephrolithiasis (calculi in the kidneys)
Skin discolouration (change of skin colour)
Weight decreased
Peripheral sensorimotor neuropathy (damage to one or more of your peripheral nerves)

male:

Altered state of consciousness (altered state of mind)
Chronic kidney disease
Fall
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Renal failure (kidney dysfunction)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Toxic encephalopathy (a degenerative neurologic disorder caused by exposure to toxic substances)

What are the common drug interactions of Alphagan P and Indapamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Peripheral sensorimotor neuropathy (damage to one or more of your peripheral nerves)
Altered state of consciousness (altered state of mind)
Intraocular pressure increased
Nasal dryness (dry nose)
Nephrolithiasis (calculi in the kidneys)
Renal failure (kidney dysfunction)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Skin discolouration (change of skin colour)
Toxic encephalopathy (a degenerative neurologic disorder caused by exposure to toxic substances)
Weight decreased

What are the existing conditions these people have? *

High Blood Cholesterol: 4 people, 36.36%
Multiple Myeloma (cancer of the plasma cells): 3 people, 27.27%
Thyroid Diseases: 1 person, 9.09%
Sinus Disorder (disease of sinus): 1 person, 9.09%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 9.09%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 9.09%
Pain: 1 person, 9.09%
Osteoporosis (bones weak and more likely to break): 1 person, 9.09%
Ill-Defined Disorder: 1 person, 9.09%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Alphagan p and Indapamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously